140 related articles for article (PubMed ID: 8640342)
1. Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain.
Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
Br J Pharmacol; 1995 Oct; 116(3):2033-9. PubMed ID: 8640342
[TBL] [Abstract][Full Text] [Related]
2. Effects of thiocyanate and AMPA receptor ligands on (S)-5-fluorowillardiine, (S)-AMPA and (R,S)-AMPA binding.
Hawkinson JE; Espitia SA
Eur J Pharmacol; 1997 Jun; 329(2-3):213-21. PubMed ID: 9226415
[TBL] [Abstract][Full Text] [Related]
3. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine.
Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471
[TBL] [Abstract][Full Text] [Related]
4. A novel kainate receptor ligand [3H]-(2S,4R)-4-methylglutamate: pharmacological characterization in rabbit brain membranes.
Toms NJ; Reid ME; Phillips W; Kemp MC; Roberts PJ
Neuropharmacology; 1997; 36(11-12):1483-8. PubMed ID: 9517418
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites.
Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T
J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain.
Dev KK; Petersen V; Honoré T; Henley JM
J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new AMPA receptor radioligand, [3H]2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid.
Stensbøl TB; Sløk FA; Trometer J; Hurt S; Ebert B; Kjøller C; Egebjerg J; Madsen U; Diemer NH; Krogsgaard-Larsen P
Eur J Pharmacol; 1999 Jun; 373(2-3):251-62. PubMed ID: 10414446
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections.
Nielsen EO; Johansen TH; Wätjen F; Drejer J
J Neurochem; 1995 Sep; 65(3):1264-73. PubMed ID: 7543932
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase potentiates [3H]fluorowillardiine and [3H]AMPA binding to rat cortical membranes.
Olivera S; Rodriguez-Ithurralde D; Henley JM
Neuropharmacology; 1999 Apr; 38(4):505-12. PubMed ID: 10221754
[TBL] [Abstract][Full Text] [Related]
10. In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.
Schaffhauser H; Richards JG; Cartmell J; Chaboz S; Kemp JA; Klingelschmidt A; Messer J; Stadler H; Woltering T; Mutel V
Mol Pharmacol; 1998 Feb; 53(2):228-33. PubMed ID: 9463480
[TBL] [Abstract][Full Text] [Related]
11. Binding characteristics of a potent AMPA receptor antagonist [3H]Ro 48-8587 in rat brain.
Mutel V; Trube G; Klingelschmidt A; Messer J; Bleuel Z; Humbel U; Clifford MM; Ellis GJ; Richards JG
J Neurochem; 1998 Jul; 71(1):418-26. PubMed ID: 9648892
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic characterization of [3H]6-cyano-7-nitroquinoxaline-2,3-dione binding sites in adult chick brain.
Zavitsanou K; Mitsacos A; Kouvelas ED
Neuroscience; 1994 Oct; 62(3):955-62. PubMed ID: 7532837
[TBL] [Abstract][Full Text] [Related]
13. AMPA receptor potentiation by acetylcholinesterase is age-dependently upregulated at synaptogenesis sites of the rat brain.
Olivera S; Henley JM; Rodriguez-Ithurralde D
Int J Dev Neurosci; 2003 Feb; 21(1):49-61. PubMed ID: 12565696
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea.
Sakai R; Swanson GT; Shimamoto K; Green T; Contractor A; Ghetti A; Tamura-Horikawa Y; Oiwa C; Kamiya H
J Pharmacol Exp Ther; 2001 Feb; 296(2):650-8. PubMed ID: 11160654
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the interaction between guanyl nucleotides and AMPA receptors in rat brain.
Dev KK; Roberts PJ; Henley JM
Neuropharmacology; 1996; 35(11):1583-93. PubMed ID: 9025106
[TBL] [Abstract][Full Text] [Related]
16. Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators.
Kessler M; Arai AC
Brain Res; 2006 Mar; 1076(1):25-41. PubMed ID: 16256076
[TBL] [Abstract][Full Text] [Related]
17. Selective loss of binding sites for the glutamate receptor ligands [3H]kainate and (S)-[3H]5-fluorowillardiine in the brains of rats with acute liver failure.
Michalak A; Butterworth RF
Hepatology; 1997 Mar; 25(3):631-5. PubMed ID: 9049210
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione.
Hatziefthimiou A; Mitsacos A; Kouvelas ED
J Neurosci Res; 1994 Feb; 37(3):392-7. PubMed ID: 7909852
[TBL] [Abstract][Full Text] [Related]
19. Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics.
Kurumaji A; Ishimaru M; Toru M
J Neurochem; 1992 Sep; 59(3):829-37. PubMed ID: 1379631
[TBL] [Abstract][Full Text] [Related]
20. Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay.
Murphy DE; Snowhill EW; Williams M
Neurochem Res; 1987 Sep; 12(9):775-81. PubMed ID: 2890112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
